logo
logo
logo

Faculty Profile : Dr. Gautam Kumar

Name: Dr. Gautam Kumar


Assistant Professor (Adhoc)
gautam.kumar2@niperhyd.ac.in
+91 40 23074750 Extn- 2033
Google Scholar Citations


ADDRESS, ROOM NO


Department of Natural Products
Room No: 03
NIPER Hyderabad
Department of Pharmaceuticals (Govt. of India)
Balanagar, Hyderabad - 500037, TS, INDIA



Experience

  1. Assistant Professor, Department of Natural Products at NIPER Hyderabad - 2021 - Present
  2. Post Doctoral Fellow at IIT Bombay, Mumbai, India - June 2019 to August 2021
  3. Research Associate at Sphaera Pharma Pvt. Ltd., IMT Manesar, Haryana, India - August 2018 to May 2019
  4. Junior Research Fellow at NIPER Mohali, India - October 2014 to June 2015
  5. Junior Research Fellow at IIT Madras, Chennai, India – June 2014 to July 2015



QUALIFICATION: (REVERSE CHRONOLOGICAL ORDER)

  1. PhD : NIPER Mohali, Mohali, India - June 2018
  2. M.Pharm.: Jamia Hamdard University, New Delhi, India - 2013
  3. B.Pharm.: Jamia Hamdard University, New Delhi, India - 2011



COURSES HANDLING(PHD/M.S(PHARM))

  1. M. Pharm: NP - 520 (Natural Products- I)

PHD STUDENTS/MASTERS STUDENTS

Masters: Completed: 05, Ongoing: 08
Ph.D Ongoing: 01


AWARDS / HONOURS

  1. Post-Doctoral fellowship from IIT Bombay, Mumbai, India
  2. Doctoral fellowship from Department of Pharmaceuticals, Ministry of chemicals and Fertilizers, New Delhi, India


RESEARCH AREAS/INTEREST

  1. Synthesis and development of anti-tubercular and anti-cancer agents
  2. Reporters for probing Mycobacteria and other microorganisms
  3. Bioactivity guided fraction, phytochemical investigation and standardization of Natural Products
  4. Semis-synthesis of bioactive natural products
  5. Development of herbal formulations



SPONSORED PROJECTS

Nil



FELLOWSHIPS / GRANTS

Nil



PUBLICATIONS / BOOK CHAPTERS

  1. Kritika Engle, Gautam Kumar: Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update. Eur. J. Med. Chem. 2022, 239, 114542
  2. Gautam Kumar, Rishikesh Narayan and Shobhna Kapoor: Chemical tools for illumination of tuberculosis biology, virulence mechanisms and diagnosis. J. Med. Chem. 2020, 63, 24, 15308-15332.
  3. Gautam Kumar, Asawari Sathe, Vagolu Siva Krishna, Dharmarajan Sriram, and Sanjay M. Jachak: Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents. Eur. J. Med. Chem. 2018, 157, 1-13.
  4. Gautam Kumar, Vagolu Siva Krishna, Dharmarajan Sriram, and Sanjay M. Jachak: Synthesis of carbohydrazides and carboxamides analogues as anti-tubercular agents. Eur. J. Med. Chem. 2018, 156, 871-884.
  5. Gautam Kumar, Ambati Goutami Godavari, Rushikesh Tambat, Siva Kumar, Hemraj Nandanwar, M. Elizabeth Sobhia, and Sanjay M. Jachak. Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors. Bioorg. Chem. 2020, 104, 104225, 1-17.
  6. Gautam Kumar, Omprakash Tanwar, Jitendra Kumar, Mymoona Akther, Supriya Sharma, C.R. Pillai, Md. Mumtaz Alam, and M.S. Zama. Pyrazole- pyrazoline as promising novel antimalarial agents: A mechanistic study. Eur. J. Med. Chem. 2018, 149, 139-147.
  7. Gautam Kumar, Vagolu Siva Krishna, Dharmarajan Sriram, and Sanjay M. Jachak: Pyrazole–coumarin and pyrazole–quinoline chalcones as potential antitubercular agents. Arch. Pharm. 2020, 1-14.
  8. Omprakash Tanwar, Gridhar Singh Deora, Lalima Tanwar, Gautam Kumar, Sridhara Janardhan, Md. Mumtaz Alam, Md. Shaquiquzzaman, and Mymoona Akther. Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations. J Mol Model. (2014) 20:2118.



PATENTS

Nil



INVITED TALKS

Nil



LABORATORY FACILITIES DEVELOPED

Under development



ADDITIONAL RESPONSIBILITIES

NIL



ANY OTHER INFORMATION

Nil